Susan Hasty, Publisher
Table of Contents . . . March 9th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
Blood Substitutes - Bovine Hemoglobin-Based Oxygen Carrier Extends Early Survival
Anemia - Method Improves Evaluation of Developing Anemia
Diagnostics - Reverse Transcriptase-Polymerase Chain Reaction Detects False-Positives
HCV Lookback - Notifications of Possible HCV Infection Could Be Minimized
Hematopoiesis - Granulocyte Colony-Stimulating Factor Increases Stem Cells
Hemoglobinopathies - Multi-Ribozyme Targeting Used in Gene Therapy Strategy
Kappa Proteins - Influence on Phenotype and Behavior of Cells Studied
Nosocomial Infection - Nurse Staff Composition May Be Related to Blood Infection Rates
Priapism - Treatment Reverses Condition in Sickle Cell Patients
Stem Cells - Filgrastim Alone or with Sargramostim Aids Neutrophil Recovery
TT Virus - No Association Found between Infection and Blood Exposure
TT Virus - Transmission Is Not Only Through Blood
Thalassemia - Drug for Iron Overload Passes Major Safety Hurdle
Thrombocytopenia - Thrombopoietin Gene Therapy Tested in Mice
Thrombosis - Co-inheritance of Hypoplasminogenemia, Factor V Leiden Does Not Increase Risk
Transfusion - Plasma Activates Release of Inflammatory Cytokines
Antibody Neutralization - AB0 Blood Group Antigens on Viruses Serve as Targets for Neutralizing Antibodies
Blood Substitutes - Patients Could Be "Own Blood Donors" During Surgery
Creutzfeldt-Jakob Disease - Diffusion-Weighted Imaging Technique Is Recommended
Blood Banking - FDA Approves Blood Donor Management Software
Hematopoiesis - Filgrastim Derivative Sustains Elevated Neutrophil Counts
Hemophilia - Foundation Provides Current Status and Availability of Recombinant Coagulation Factor VIII
Hemophilia - Gene Holds Promise for Development of Therapy
Lymphoma - Mi15 MAb Is a Reliable Marker for Quantifying Plasma Cells
Thrombosis - Treatment for Heparin-Induced Thrombocytopenia Receives Nod from FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.